BPC 157 No Proof Required! Office for Science and Society McGill University The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 in Australia: Benefits, side effects, risks and legality BPC 157 TB 500 Blend 10MG Research Peptide Combination